MedTrace Logo

Myocardial Infarction Prescription Duration Adherence Study

NCT03257579 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20896

Last updated 2022-03-16

No results posted yet for this study

Summary

Quasi-experimental, controlled interrupted time series design, evaluating the impact of the intervention at Hamilton Health Sciences (HHS) where standardized prescriptions and education will be provided and St Joseph's Hospital (SJH) and Niagara Health Services (NHS) where education alone will be provided, with remaining Ontario cardiac sites as a concurrent control group.

Conditions

  • Medication Adherence

Interventions

OTHER

90 Day Supply

Policy Change implementing a 90 day standardized discharge prescription form with 3 repeats for all cardiac medications available on all wards where MI patients are managed at Hamilton Health Sciences sites

BEHAVIORAL

Education

Education Alone provided at St. Joseph's Hospital and Niagara Health System

Sponsors & Collaborators

  • Population Health Research Institute

    collaborator OTHER

  • Institute for Clinical Evaluative Sciences

    collaborator OTHER

  • Hamilton Health Sciences Corporation

    lead OTHER

Principal Investigators

  • Jon-David Schwalm, MD,FRCPC,MSc · 905-577-1423

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-05
Primary Completion
2018-09-30
Completion
2021-07-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03257579 on ClinicalTrials.gov